ELDN (Eledon Pharmaceuticals) Cyclically Adjusted Book per Share: $39.38 (As of Mar. 2026)


ELDN Eledon Pharmaceuticals Inc ELDN
21 GF Score
Price $3.95
! 2 Warning Signs
View Full Analysis

What is Eledon Pharmaceuticals Cyclically Adjusted Book per Share?

Eledon Pharmaceuticals ELDN +1.28% 21 Cyclically Adjusted Book per Share is $39.38 as of Mar. 2026. GuruFocus rates ELDN with a GF Score™ of 21/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Eledon Pharmaceuticals's adjusted book value per share for the three months ended in Mar. 2026 was $0.590. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $39.38 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Eledon Pharmaceuticals's average Cyclically Adjusted Book Growth Rate was -58.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-07-03), Eledon Pharmaceuticals's current stock price is $3.945. Eledon Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $39.38. Eledon Pharmaceuticals's Cyclically Adjusted PB Ratio of today is 0.10.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Eledon Pharmaceuticals was 0.10. The lowest was 0.00. And the median was 0.00.


Eledon Pharmaceuticals  (NAS:ELDN) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Eledon Pharmaceuticals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=3.945/39.38
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Eledon Pharmaceuticals was 0.10. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Eledon Pharmaceuticals Cyclically Adjusted Book per Share Related Terms


Eledon Pharmaceuticals Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Eledon Pharmaceuticals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eledon Pharmaceuticals Cyclically Adjusted Book per Share Chart

Eledon Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 177.89 123.34 51.12

Eledon Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 102.72 83.51 66.46 51.12 39.38

ELDN vs ZNTL, GLSI, SABS: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Eledon Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eledon Pharmaceuticals Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Eledon Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Eledon Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.


ELDN
21GF Score
Eledon Pharmaceuticals Inc ELDN
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eledon Pharmaceuticals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Eledon Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.59/330.2130*330.2130
=0.590

Current CPI (Mar. 2026) = 330.2130.

Eledon Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201606 277.743 241.018 380.529
201609 216.121 241.428 295.599
201612 -21.514 241.432 -29.425
201703 166.886 243.801 226.037
201706 60.723 244.955 81.858
201709 53.417 246.819 71.465
201712 49.246 246.524 65.964
201803 46.459 249.554 61.475
201806 41.134 251.989 53.903
201809 35.038 252.439 45.833
201812 27.709 251.233 36.420
201903 18.912 254.202 24.567
201906 22.236 256.143 28.666
201909 18.538 256.759 23.841
201912 13.146 256.974 16.893
202003 13.152 258.115 16.826
202006 8.687 257.797 11.127
202009 16.867 260.280 21.399
202012 12.572 260.474 15.938
202103 12.852 264.877 16.022
202106 12.478 271.696 15.165
202109 11.935 274.310 14.367
202112 11.463 278.802 13.577
202203 11.363 287.504 13.051
202206 10.858 296.311 12.100
202209 10.256 296.808 11.410
202212 6.110 296.797 6.798
202303 5.429 301.836 5.939
202306 4.337 305.109 4.694
202309 3.879 307.789 4.162
202312 -2.002 306.746 -2.155
202403 3.015 312.332 3.188
202406 -0.221 314.175 -0.232
202409 1.847 315.301 1.934
202412 1.044 315.605 1.092
202503 1.913 319.799 1.975
202506 0.841 322.561 0.861
202509 0.590 324.800 0.600
202512 1.075 324.054 1.095
202603 0.590 330.213 0.590

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $39.38 mean?
Eledon Pharmaceuticals (ELDN) has a Cyclically Adjusted Book per Share of $39.38 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Eledon Pharmaceuticals and its competitors.
Is Eledon Pharmaceuticals' Cyclically Adjusted Book per Share too high?
Eledon Pharmaceuticals' current Cyclically Adjusted Book per Share is $39.38. Overall, Eledon Pharmaceuticals has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Eledon Pharmaceuticals' Cyclically Adjusted Book per Share compare to ZNTL and GLSI?
Eledon Pharmaceuticals' Cyclically Adjusted Book per Share of $39.38 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Eledon Pharmaceuticals and its competitors. Eledon Pharmaceuticals's current Cyclically Adjusted Book per Share is $39.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eledon Pharmaceuticals stock overvalued right now?
Eledon Pharmaceuticals (ELDN) has a current Cyclically Adjusted Book per Share of $39.38. The current Cyclically Adjusted Book per Share is $39.38. Eledon Pharmaceuticals' overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Eledon Pharmaceuticals (ELDN), the current Cyclically Adjusted Book per Share is $39.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Eledon Pharmaceuticals Business Description

Other Exchanges 2TK:Germany
Address 19800 MacArthur Boulevard, Suite 250, Irvine, CA, USA, 92612
Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.
21GF Score

Get the complete analysis for ELDN

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.95
Price